Information on new approvals and medication safety that rheumatologists need to know
2013 ACR/ARHP Annual Meeting: Genetic Research Yields Clues to Pathogenesis of Rheumatoid Arthritis, Psoriatic Arthritis
Studies determine that both RA and PsA are autoimmune diseases and link disease susceptibility to certain alleles that encode the major histocompatibility complex, HLA
2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis
Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA
2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate
Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives
Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis
Funds help scientists explore role of neutrophil extracellular traps in the pathogenesis of RA
Letters: Criticism for Complementary and Alternative Medicine Therapies in Rheumatoid Arthritis
One reader calls claims about the effectiveness of CAM to treat RA misleading; author notes proving the efficacy of alternative treatments remains challenging
What Diet to Recommend to Patients with Rheumatoid Arthritis?
With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis
Rheumatologists Explore Connection Between Tooth Loss and Rheumatoid Arthritis
Studies funded by the Rheumatology Research Foundation link bacteria that contributes to gum disease to increased risk of developing RA
Survey Highlights High Out-of-pocket Costs for RA Care
The “RA in America 2013″ survey estimates out-of-pocket cost for RA treatment at $1,000 to $5,000 per year. (posted Oct. 25)
Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia
A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy. (posted Oct. 3, 2013)
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 45
- Next Page »